Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Nellix Registry Study: EVAS-Global

NCT: NCT02996396 · COMPLETED

NCT IDNCT02996396
StatusCOMPLETED
Start Date2016-11
Completion2024-02-27
SponsorEndologix (INDUSTRY)
First posted
Last updated

Brief Summary

Multicenter, single arm, open label, registry study with consecutive, eligible patient enrollment at each site. All subjects undergoing the Endovascular Aneurysm Sealing System (EVAS) with the Nellix®-System. Subjects will be followed procedurally to discharge, and as per institutional standard of care thereafter through to 5 years (total follow-up commitment)

Frequently Asked Questions

What is Nellix Registry Study: EVAS-Global?

Nellix Registry Study: EVAS-Global is a clinical trial registered under NCT02996396. Current status: COMPLETED.

What is the status of NCT02996396?

The current status of NCT02996396 (Nellix Registry Study: EVAS-Global) is: COMPLETED.

When did Nellix Registry Study: EVAS-Global start?

Nellix Registry Study: EVAS-Global started on 2016-11.

Related Devices

PMA P040002SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENTEndologix, LLC PMA P120006SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENTEndologix, LLC PMA P220021Stent graft, bypass, superficial femoral arteryEndologix, LLC

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑